A recent study reveals that people who discontinue new GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass far faster than those who stop conventional diet and exercise programs.
Research printed in a leading health publication shows that while obese people frequently drop about a fifth of their total mass while on the medication, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals purchasing these medications should be informed of the potential of quick weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment mass within about one and a half years.
Analyzing Therapies
The research, which looked at dozens of trials involving over 9,000 of participants, compared the effects of these new drugs with other pills.
Scientists note that people who shed pounds through diet and exercise typically see a more gradual creep back—approximately 100 grams monthly—post-intervention.
Understanding the Fast Regain
Nutrition scientists suggest the way of the jabs accounts for the heightened weight return.
The injections copy a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Artificially providing GLP-1 concentrations several times higher than normal could lead to the system to produce less of its own natural hormone, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making binge eating far more likely."
A Lifelong Disease?
Health authorities suggest the jabs for people with obesity-related health risks, alongside recommended diet and exercise modifications.
A number of clinicians contend that, due to the significant potential of relapse, the therapy is often life-long.
This perspective is reinforced by drug manufacturers, who note that the findings "highlight the long-term nature of obesity," similar to managing conditions like hypertension.
User Accounts
Individuals who have stopped the medication explain a intense resurgence of hunger.
"I experienced something activating and I was suddenly extremely hungry," said one woman.
This difficulty is compounded if users have not adopted lasting lifestyle or habit modifications during treatment.
Significant Interest
Survey data indicate that millions of people in the UK have used these injections in the past year, with demand being substantial.
- Use is more common among women than males.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
Ultimately, experts emphasize that while the jabs are potent agents for shedding pounds, they are not a standalone solution and lasting health benefits likely depends on ongoing lifestyle management.
